Literature DB >> 11136204

Influence of socio-economic deprivation on the prevalence and outcome of depression in primary care: the Hampshire Depression Project.

K Ostler1, C Thompson, A L Kinmonth, R C Peveler, L Stevens, A Stevens.   

Abstract

BACKGROUND: Health inequalities exist for many disorders, but the contribution of deprivation to the prevalence and outcome of depressive symptoms in primary care populations has been infrequently studied. AIMS: To examine the influence of Jarman under-privileged area (UPA) scores on the prevalence and outcome of depressive symptoms in general practice patients.
METHOD: 18 414 patients attending 55 representative practices completed the Hospital Anxiety and Depression Scale and a questionnaire for employment status. Outcome of those screening positive was assessed at 6 weeks and 6 months.
RESULTS: The UPA score accounted for 48.3% of the variance between practices in prevalence of depressive symptoms. Attending a high UPA score practice predicted persistence of depressive symptoms to 6 months.
CONCLUSIONS: The socio-economic deprivation of a practice locality is a powerful predictor of the prevalence and persistence of depressive symptoms.

Entities:  

Mesh:

Year:  2001        PMID: 11136204     DOI: 10.1192/bjp.178.1.12

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  32 in total

Review 1.  EPA guidance on mental health and economic crises in Europe.

Authors:  M Martin-Carrasco; S Evans-Lacko; G Dom; N G Christodoulou; J Samochowiec; E González-Fraile; P Bienkowski; M Gómez-Beneyto; M J H Dos Santos; D Wasserman
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-02-13       Impact factor: 5.270

2.  A randomized trial of collaborative depression care in obstetrics and gynecology clinics: socioeconomic disadvantage and treatment response.

Authors:  Wayne Katon; Joan Russo; Susan D Reed; Carmen A Croicu; Evette Ludman; Anna LaRocco; Jennifer L Melville
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

Review 3.  Depressive symptoms and their social contexts: a qualitative systematic literature review of contextual interventions.

Authors:  Laura Gottlieb; Howard Waitzkin; Jeanne Miranda
Journal:  Int J Soc Psychiatry       Date:  2010-03-30

4.  Psychosocial, psychopharmacological and demographic predictors of changes in psychological distress over a course of computerised cognitive behavioural therapy (cCBT).

Authors:  Fabia Cientanni; Kevin Power; Christopher Wright; Fabio Sani; Diane Reilly; Marie-Louise Blake; Kerry Hustings; David Morgan; Stella Clark
Journal:  Internet Interv       Date:  2019-04-27

5.  Explaining the variation between practices in the duration of new antidepressant treatment: a database cohort study in primary care.

Authors:  Christopher Burton; Isobel Cameron; Niall Anderson
Journal:  Br J Gen Pract       Date:  2015-02       Impact factor: 5.386

6.  Ethnicity and Psychiatric Disorders.

Authors:  Armani M Hawes; William G Axinn; Dirgha J Ghimire
Journal:  Ann Psychiatry Ment Health       Date:  2016-06-16

7.  GP treatment decisions for patients with depression: an observational study.

Authors:  Tony Kendrick; Fiona King; Louise Albertella; Peter Wf Smith
Journal:  Br J Gen Pract       Date:  2005-04       Impact factor: 5.386

Review 8.  Do antidepressants reduce the burden imposed by depression on employers?

Authors:  Mark J Greener; Julian F Guest
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

9.  Does financial disadvantage at older ages eliminate the potential for better health?

Authors:  Scott M Montgomery; Gopalakrishnan Netuveli; Zoe Hildon; David Blane
Journal:  J Epidemiol Community Health       Date:  2007-10       Impact factor: 3.710

10.  Who is treated, and how, for depression? An analysis of statutory health insurance data in Germany.

Authors:  Anke Bramesfeld; Thomas Grobe; Friedrich Wilhelm Schwartz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-06-27       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.